MyMA's Most Read - Nov 2024
My Medical Affairs
Your gateway to the world of medical affairs events, content and resources - curated to your role and interests.
Dive into the perfect reads that will captivate, entertain, and enlighten you!
This month's most read includes such a variety, we're certain our top picks offer something for everyone—or perhaps everything for some...
Happy Reading!! 📚
1. 2024 Digital, Advanced Analytics and Artificial Intelligence (AI) in Medical Affairs report
Based on the findings from survey respondents from over 30 leading organisations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors, Medical Affairs Professional Society (MAPS) 's report reflects the insights and foresights into the current and future states of Medical Affairs (MA) AI, encompassing both capabilities and challenges individuals and companies are and will face.
With a special thanks to participants from 3M , Abbott , AbbVie , Amgen , Astellas Pharma , AstraZeneca , Baxter International Inc. , Bayer , bioMérieux , BioNTech SE , Bristol Myers Squibb , Eisai Co., Ltd. , Eli Lilly and Company , Gilead Sciences , Ipsen , Jazz Pharmaceuticals , Kyowa Kirin International plc. , Lundbeck , Mallinckrodt Pharmaceuticals , Merck Group , Mundipharma , Novartis , Otsuka Pharmaceutical Co., Ltd. , Regeneron , Sanofi , Sumitomo Pharma America, Inc. , Takeda , Teva Pharmaceuticals , UCB , Varian , Vertex Pharmaceuticals , and Viatris for their valuable feedback and insights.
(The opinions expressed here are those of members of the MAPS Ambassador Alliance and do not necessarily represent the perspectives of their respective companies).
2. Medical Science Liaisons: A Guide for Advanced Practice Registered Nurses
By Joyce C. , Dr. Gregory Burns DHSc, PA-C, DFAAPA , Crystal Kelly, DHSc, APRN, FNP , Dawn Vanderhoef , Jessica Johnson - Published on Elsevier
Understanding MSL engagement allows APRNs multiple avenues both externally and within the pharmaceutical industry to leverage their experience to enhance clinical practice.
An unique and insightful paper focusing on the role of an MSL and their partnerships with Advance Practice Registered Nurses (APRNs). Exploring how MSLs and APRNs can leverage each other to advance their practice and results. This collaboration is a powerful opportunity to boost expertise, elevate patient outcomes, and stay at the forefront of medical advancements.
Well worth the read for all field teams and clinicians!
3. How to satisfy the curious Key Opinion Leader
By EMJ GOLD
How can companies best leverage their KOLs earlier in the product lifecycle, and how do KOLs themselves want to be involved?
Join Saša Janković as they explore effective strategies for engaging key stakeholders—physicians, hospital executives, health system directors, researchers, patient advocacy group members, and more—to unlock the essential insights your team needs.
Recommended by LinkedIn
4. The strategic role of publications in empowering Health Professionals
By solli (Sponsored by Medscape Medical Affairs )
The medical landscape is evolving at an astonishing pace, inundating healthcare professionals (HCPs) with new data daily. Medical Affairs professionals work tirelessly to ensure impactful clinical insights reach the right audience at the right time. But the challenge extends beyond distribution—it’s about delivering data that resonates and empowers HCPs in their decision-making, ultimately enhancing patient care.
In an era where information comes from countless sources, peer-reviewed publications remain the most trusted resource for HCPs.
Despite the high level of trust that clinicians place in publications, awareness of new studies tends to wane rapidly after their initial release. To maintain relevance and reach, there is an increasing need to extend the lifecycle of publications and communicate new findings in ways that keep the data top of mind for HCPs.
Join the solli team as they explore the critical role of publications and share strategies to extend their reach and impact.
5. Unlocking innovation: the value of Open Access in scientific publications
By Altmetric
Join Catherine Skobe and Seth James , in there report in collaboration with Digital Science 's Misha Kidambi , as they explore how open access can change the game in the world of biomedical research.
Open access not only enables faster sharing of groundbreaking data but also encourages collaboration, transparency, and equity in research. For medical and scientific professionals, understanding the benefits of open access can help in leveraging cutting-edge insights that contribute to patient care, healthcare solutions, and informed decision-making. This article sheds light on the transformative impact of open access on the future of science and medicine, making it a must-read for anyone involved in healthcare or scientific research.
It truly has been a fantastic month of content on MyMA!
We hope you’ve discovered something engaging, inspiring, or even a welcome break from your usual feed.
Share your favorite article with a friend or colleague, and explore more live and on-demand content on MyMedicalAffairs.com.
With special thanks to our partners: Wiley Corporate Solutions , Springer Healthcare , Altmetric and DIA .